Red White & Bloom Brands Inc. (CNSX: RWB)
Health Care · Pharmaceuticals · CA
CA$0.03
+50.00% today · -45.5% 1Y
Red White & Bloom Brands Inc. (CNSX: RWB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.25M and employs 800 people.
Over the last twelve months the share price has lost 45.5%, trading between 0.01 and 0.20.
Tweenvest scores Red White & Bloom Brands Inc. across four factors: quality 27/100, value 59/100, growth 0/100. Its strongest factor is value.
RWB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.25M
- Revenue (TTM)
- $42.68M
- P/E
- —
- EPS
- -0.19
- Dividend yield
- —
- Beta (5Y)
- -0.65
- 52-week high
- CA$0.20
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 470.60M
- Employees
- 800
- Next earnings
- —
About Red White & Bloom Brands Inc.
Red White & Bloom Brands Inc. is actively involved in the cultivation and sale of cannabis goods. It maintains a significant operational footprint primarily across Michigan, California, Florida, and Oklahoma. The enterprise is based in Vancouver, Canada.
- ISIN
- CA75704R1010
- Listed since
- Jun 5, 2020
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.00 | -0.07% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.00 | -0.75% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.75 | +0.06% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.00 | +0.16% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.66 | +0.46% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.89 | -0.29% |
Figures last refreshed Aug 18, 2026.